Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

High Annual Risk of Tuberculosis Infection among Nursing Students in South India: A Cohort Study

High Annual Risk of Tuberculosis Infection among Nursing Students in South India: A Cohort Study

  • Devasahayam J. Christopher, 
  • Prince James, 
  • Peter Daley, 
  • Lois Armstrong, 
  • Barney T. J. Isaac, 
  • Balamugesh Thangakunam, 
  • Beulah Premkumar, 
  • Alice Zwerling, 
  • Madhukar Pai
PLOS
x

Abstract

Background

Nurses in developing countries are frequently exposed to infectious tuberculosis (TB) patients, and have a high prevalence of TB infection. To estimate the incidence of new TB infection, we recruited a cohort of young nursing trainees at the Christian Medical College in Southern India. Annual tuberculin skin testing (TST) was conducted to assess the annual risk of TB infection (ARTI) in this cohort.

Methodology/Principal Findings

436 nursing students completed baseline two-step TST testing in 2007 and 217 were TST-negative and therefore eligible for repeat testing in 2008. 181 subjects completed a detailed questionnaire on exposure to tuberculosis from workplace and social contacts. A physician verified the questionnaire and clinical log book and screened the subjects for symptoms of active TB. The majority of nursing students (96.7%) were females, almost 84% were under 22 years of age, and 80% had BCG scars. Among those students who underwent repeat testing in 2008, 14 had TST conversions using the ATS/CDC/IDSA conversion definition of 10 mm or greater increase over baseline. The ARTI was therefore estimated as 7.8% (95%CI: 4.3–12.8%). This was significantly higher than the national average ARTI of 1.5%. Sputum collection and caring for pulmonary TB patients were both high risk activities that were associated with TST conversions in this young nursing cohort.

Conclusions

Our study showed a high ARTI among young nursing trainees, substantially higher than that seen in the general Indian population. Indian healthcare providers and the Indian Revised National TB Control Programme will need to implement internationally recommended TB infection control interventions to protect its health care workforce.

Introduction

Tuberculosis (TB) continues to be a global killer, with over 9 million new cases of active disease diagnosed every year.[1] Health care workers (HCW) serve on the front lines of the battle against TB, and the risk of infection among HCWs is especially high. [2], [3] In a systematic review of studies from low and middle income countries, the annual risk of TB infection (LTBI) was found to vary between 0.5% to 14.3% in HCWs, while the annual incidence of TB disease ranged from 69–5,780 cases per 100 000 HCWs.[2] In recent years, the emergence of multi drug-resistant (MDR) and extensively drug resistant (XDR) TB strains have sparked a renewed interest in and emphasis on the protection of the healthcare workforce. In 2009, the World Health Organization released guidelines on TB Infection Control (TBIC) in resource limited settings, and is now actively promoting TBIC programmes.[4] TB infection control is also included in the 3-Is initiative (infection control, isoniazid preventive therapy [IPT], and intensive case finding) by the WHO, especially in countries with high prevalence of HIV.

HCWs in high TB burden settings are at higher risk of developing LTBI, compared with the general population, because of their exposure to large numbers of smear-positive TB cases managed at hospitals or health care centers. Nurses, in particular, spend a lot of time caring for smear positive and smear negative pulmonary TB patients, and are particularly at risk for acquisition of LTBI[2]. A study from central India reported LTBI prevalence proportions of around 40% among Indian HCWs using either the tuberculin skin test (TST) or the novel interferon-gamma release assays (IGRA)[5]. The study found an increased prevalence of LTBI with increasing age, and years worked in health care. [5] Similarly, the annual risk of TB infection (ARTI) among medical and nursing trainees was found to be 5%, 3 times higher than the 1.5% estimated ARTI for the general population in India. [6]

Traditionally, screening HCWs for LTBI was done with the Tuberculin Skin Test (TST), however there are some limitations for its use in serial testing HCWs, including: complications with boosting and conversions.[7] In recent years, the introduction of novel IGRAs have provided an alternative to the 100 year old TST. There are two IGRAs commercially available: the TSPOT.TB assay (Oxford Immunotech, Abingdon, UK) and the QuantiFERON-TB Gold In-Tube (QFT) assay (Cellestis Ltd, Carnegie, Australia). These IGRA assays have some advantages over the TST including not being affected by prior BCG vaccination or non TB mycobacterial (NTM) infection. IGRAs are in vitro tests and eliminate concerns regarding adverse events or boosting and do not require a return visit.[8], [9], [10], [11] The use of IGRAs in HCWs is increasing and there are several published studies and two systematic reviews published.[12], [13] While these assays show promise for screening in low incidence settings, they appear to have lower sensitivity in high incidence settings such as India[8], [12] and predictive (prognostic) value of both TST and IGRA for identifying those at highest risk of progressing to active TB disease appear to be limited, especially in high TB burden settings.[14]

In an effort to better understand nosocomial TB among nursing trainees in Southern India, we initiated a cohort study among nursing students training at a large tertiary care hospital. Our earlier publication on this cohort of young nursing trainees reported a high LTBI prevalence of 47.8% using latent class analysis (95% credible interval: 17.8%–65.6%).[15] We now report the results from annual testing using TST in this cohort of nursing trainees.[15]

Methods

Study Design and Ethics Approvals

Our study was conducted at the Christian Medical College (CMC) in Vellore, India. Nursing students at the college were approached for enrollment in the study in the year 2007 and were followed up prospectively at yearly intervals. TST was repeated annually, but only if previously negative. Students with a positive TST result were assessed for active TB, and TST was not repeated in these individuals. Baseline demographics and results of cross-sectional testing of this cohort have been published previously.[15]

All study participants were aged 18 or more, and all participants provided written informed consent. The study protocol was approved by the institutional review boards at both Christian Medical College Hospital, Vellore, India and McGill University, Montreal, Canada. All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki.

Setting & Study Participants.

The CMC is a large (2200 beds) tertiary referral medical school at Vellore, a town located in the Tamil Nadu state of Southern India. The district of Vellore has an annual TB case detection rate of 148/100,000.[16] However the hospital's patient population comes from all over India with many patients travelling substantial distances. In a previous report, we estimated a baseline prevalence of 47.8–50.2% TST positivity (95%CI: 17.8 to 65.6%), for this cohort.[15] An earlier report from the CMC described 126 cases of active TB among various health care workers at the institution over a ten year period.[17] Hospital infection control policy states that smear positive pulmonary TB patients should be admitted to the isolation ward or a single room, with closed doors and open windows, and staff are instructed to wear surgical masks when entering the room. However due to space and resource constraints, the policy is not universally implemented.

Student nurses from all 6 programs offered at the College of Nursing, CMC, Vellore were approached for inclusion in the study, including: Nursing diploma, BSc, Post diploma BSc courses, fellowship courses, MSc, and Doctoral (PhD) programs. Students with a past history of TB were excluded from the study at recruitment. The remaining eligible nursing students signed written consent forms to participate in the prospective cohort.

Measurement of exposure to TB

All nursing students at CMC routinely maintain detailed clinical log books, which were used to collect information regarding the students' likelihood of TB exposure. Students recorded if they had had direct contact with a smear positive TB patient, and the number of days spent working on various medical wards.

Data were ascertained from clinical log books at baseline and at testing 1 year later. Log books helped identify students who had been exposed to TB and to quantify the number of days spent caring for pulmonary TB patients, since baseline testing. Other exposure information ascertained included: days worked on isolation, pulmonary medicine, and general medicine wards, number of times performed or assisted in sputum collection, all since baseline testing. At both baseline and annual testing, students were asked about exposure to TB outside the hospital setting.

TST testing & Interpretation

Students were tested with TST at baseline using the two step TST protocol.[18] Two Tuberculin Units (0.1 ml) of RT23 PPD (Staten Serum Institute, Copenhagen) was injected intra-dermally. After 48–72 hours the induration was measured by a trained reader. An induration of ≥10 mm was considered positive at baseline. If TST was negative (<10 mm) at baseline, TST was then repeated at approximately 1 year post baseline. TST was not performed at 1 year if students had been TST positive at baseline. TST conversion was defined as a baseline TST induration of <10 mm, and follow-up TST of ≥10 mm, with an increase of 10 mm, as per ATS/CDC/IDSA standards.[19]

IGRA testing (QFT)

Students were tested with the QuantiFERON-TB Gold In-Tube (QFT) test (Cellestis Ltd, Carnegie, Australia). QFT was performed per manufacturer's instructions, and the QFT was considered positive if the Interferon-gamma response of TB antigen minus the nil was ≥0.35 IU/mL. QFT was performed on all recruits at the annual screening in 2008. Given only one time point with QFT results we were not able to look at QFT conversions/reversions in this cohort, but such analyses will be possible with subsequent follow-up of this same cohort.

Management of TST Conversions

Isoniazid (INH) preventive therapy is not routinely offered to HCWs with LTBI in India because of the high background prevalence of LTBI, risks associated with drug toxicity, concern about wide-spread resistance to INH, chances of poor compliance, a high likelihood for re-exposure and re-infection, and lack of evidence that preventive therapy has long term efficacy in TB endemic populations. However, recent conversions are associated with an elevated risk of developing active TB. Therefore, students who had TST conversions upon testing at 1 year were assessed to rule out active TB and then offered preventive therapy using 4 months of Rifampicin, one of the acceptable preventive therapy regimens.[20] All students on preventive therapy were closely followed for adverse events by clinicians in the department of pulmonary medicine.

Statistical analysis

Clinical and demographic data, along with variables concerning exposure to TB for the cohort were summarized using descriptive statistics. The frequency distribution of TST measurements were displayed graphically as histograms. The main outcome was annual risk of TB infection (ARTI), with 95% confidence intervals, estimated using TST conversions as defined above. This was followed by an analysis to assess the major risk factors for TST conversions. First, univariate regression was used to assess a potential relationship between TB exposure and known clinical and occupational risk variables and a TST conversion. Finally a multivariate logistic model was fit to assess the relationship between TST conversions and known occupational risk factors for TB, variables such as age and BCG vaccination were included due to their a priori association with TST positivity despite not reaching statistical significance in univariate models. All analyses were performed using Stata 11 (Stata Corp, Texas, USA).

Results

Description of the cohort

Nursing students who were TST negative after baseline two-step testing in 2007 were approached for repeat testing in 2008.[15] Figure 1 shows the flow of participants included in the analysis. Two hundred and sixteen nursing students were TST negative and eligible for repeat testing with the TST in 2008. Nineteen nursing students had completed their training and were no longer working at the institution. A further 16 students withdrew from the study, while the remaining 181 nursing students consented to repeat testing, and 179 completed repeat testing with the TST in 2008.

The cohort was predominantly female (96.7%), 83.8% were under 22 years of age, and 80% of students had evidence of BCG vaccination. All study participants were aged 18 or more. The majority of students were enrolled in the diploma or BSc nursing programs, and the mean time spent working in health care was 34.5 months (Range:13–193; Median  = 28 IQR = 17–39). Tables 1 and 2 provide complete information on participant characteristics at time of repeat testing in 2008.

thumbnail
Table 1. Characteristics of study participants who underwent repeat tuberculin testing in 2008.

https://doi.org/10.1371/journal.pone.0026199.t001

thumbnail
Table 2. Prevalence of risk factors & TB exposure at repeat tuberculin testing in 2008.

https://doi.org/10.1371/journal.pone.0026199.t002

TB Exposure and Risk Factors

Nursing students maintained detailed clinical log books, which were used to ascertain days spent working on different wards and exposure to smear positive pulmonary patients. Sixty-five students (36.3%) had had direct contact with a smear positive TB patient as part of their nurse training since baseline testing in 2007. A further 32 students (17.9%) had had direct contact with TB patients, but were unsure if they were smear positive. Students reported a mean of 6.04 days caring for pulmonary TB patients since baseline testing (Range: 0–60 days; Median  = 4 IQR = 0–9). Since baseline testing, students reported working a mean of 4.45 days on isolation wards (Range: 0–28 days; Median  = 4 IQR = 0–6) and a mean of 0.76 days working in pulmonary medicine wards (Range: 0–14 days; Median  =  0 IQR =  0). Almost half of the cohort (43.57%) had performed or assisted with sputum collection since last TST testing. Only five students (2.79%) recalled contact with TB outside the hospital setting since baseline testing, presumably because they were all residing in the institutional hostels (dormitories).

TST Conversions and Annual Risk of TB Infection (ARTI)

Figure 2 shows the frequency distribution of TST indurations at repeat testing in 2008, measured in mm. Ninety-three students (52%) had no reaction to TST, while 34 students (19%) had an induration of 10 mm or higher. Figure 3 shows the frequency distribution for the difference in TST induration between the two test points; the plot shows that there are individuals who have had an increase in induration in the year between testing, however there are also a group of students in the left of the graph with a decrease in induration, whose baseline TST was more than 0 but less than 10 mm, yet upon annual testing their TST induration became smaller or indeed reverted to zero.

thumbnail
Figure 2. Frequency distribution of tuberculin skin test reactions at annual testing in 2008 (induration in mm).

https://doi.org/10.1371/journal.pone.0026199.g002

thumbnail
Figure 3. Frequency distribution of change in tuberculin skin test reactions since baseline testing (induration in mm).

https://doi.org/10.1371/journal.pone.0026199.g003

Using the standard ATS/CDC/IDSA definition for a TST conversion: a repeat TST induration of 10 mm or higher and an increase in induration of 10 mm over the baseline TST result, we found 14 students met the definition for TST conversion. Therefore using this definition we estimate an annual risk of TB infection (ARTI) of 7.8%, (95% CI: 4.34–12.77). Of the 14 students with conversions, 13 (93%) consented to preventive therapy and completed 4 months of daily Rifampicin therapy. No serious adverse events occurred.

QFT Results

QFT results were available for 177 out of 179 TST negative nursing students who underwent repeat testing in 2008. Using the manufacturer's cut-off, 131 students (74%) tested negative, 44 tested positive (24.9%) and two had indeterminate responses (1.1%).

Among the 14 students who met the ATS/CDC/IDSA definition for TST conversion, 9 (64.3%) were also positive by QFT in 2008, (range of IFN-gamma: 0.55–14.3 IU/mL). The remaining 5 TST converters, tested negative on QFT-GIT (range: 0.32–0.09 IU/mL).

Univariate analysis of TB Exposure and TST Conversions

Table 3 presents univariate odds ratios measuring the association between demographic and TB exposure variables and TST conversions (using the ATS/CDC/IDSA conversion definition). No demographic variables were significantly associated with TST conversions in this cohort. Among TB exposure variables: Days spent caring for pulmonary TB patients since baseline testing (OR = 1.10, 95% CI:1.04–1.17) and having performed or assisted in sputum collection since baseline testing (OR = 3.57, 95% CI:1.07–11.84) were both significantly associated with TST conversions.

thumbnail
Table 3. Association between risk factors and TST Conversions: Results of univariate logistic regression (Bolded variables reached statistical significance).

https://doi.org/10.1371/journal.pone.0026199.t003

We also looked at the association between QFT results and TST Conversions in 2008. QFT positivity (using the manufacturer's cut-off, 0.35 IU/ml) showed the strongest association with TST conversions (OR = 4.15, 95% CI:1.55–11.13), while continuous IFN-gamma responses (measured in IU/mL) were also significantly associated with conversions (OR = 1.56, 95% CI:1.2–2.02).

Multivariate analysis

Table 4 presents the results from the multivariate logistics regression analysis. We included variables that were significant in univariate analyses as well as age and BCG vaccination. Having performed or assisted in sputum collection (OR = 4.57, 95% CI: 1.11–18.86) and QFT positivity (OR = 5.89, 95% CI: 1.72–20.23) were both strongly associated with TST conversions. Days spent caring for pulmonary TB patients was also significantly associated with conversions. Therefore, sputum collection and caring for pulmonary TB patients are both high risk activities that may lead to increased risk for TST conversions in this young nursing cohort.

thumbnail
Table 4. Association of TB Exposure and risk factors with TST conversions: Results from multivariate logistic regression (Bolded variables reached statistical significance).

https://doi.org/10.1371/journal.pone.0026199.t004

Discussion

TB continues to be a major public health concern worldwide. In India, where there are more TB cases than any other country, HCWs are at higher risk for TB exposure compared to the general population. The growing concern worldwide regarding TBIC and nosocomial infection has brought attention to the problem of hospital acquired TB infection among HCWs. While our previous study[15] among Indian nursing trainees showed a high prevalence of LTBI, our current study demonstrated a very high annual risk of TB infection (ARTI) of 7.8%, several times higher than the national average of 1.5%, and represents a significantly elevated occupational risk.

We found TST conversions were associated with the 2 variables capturing occupational TB exposure namely; days spent caring for pulmonary TB patients (OR = 1.12, 95%CI: 1.04–1.20) and having performed or assisted in sputum collection. The latter was strongly associated with TST conversions, as we would expect, given the high risk nature of the procedure (OR = 4.57, 95% CI: 1.11–18.86) and also because nursing trainees at CMC do not routinely use N95 respirators while doing the procedure. This suggests that certain occupational activities may be associated with high risk of TST conversions, even in a high TB incidence setting, and suggests areas for implementation of TBIC.

The longitudinal nature of the study, ascertainment of TB exposure data from detailed clinical log books, maintained prospectively throughout the study and the ability to associate new exposures to new TST conversions represent strengths of our study. Detailed exposure data are particularly difficult to attain in a high incidence settings such as India, and this study is one of the few that have shown that TST conversions are associated with specific occupational exposures.

One study limitation is the TST itself. False positives can happen with the TST, either because of previous BCG vaccination or by sensitization to non tuberculous mycobacteria (NTM). However, BCG vaccination in India is routinely given at birth and not repeated,[21] and should therefore be unlikely to cause false positive TST reactions in adults. Also, NTM is thought to not be clinically important cause of false positives unless the prevalence of NTM is high and the prevalence of TB is low,[22] and this is not the case in Southern India. While an IGRA (QuantiFERON TB Gold) test was included in the study protocol in 2008, we do not have baseline QFT results to compare and therefore could not assess whether TST conversions are associated with QFT conversions. Future analyses of this ongoing cohort will address such questions.

The high ARTI in this cohort indicates ongoing nosocomial transmission at CMC hospital. Health care workers are the backbone in the fight against TB and we must endeavor to protect them while they care for contagious patients. Indian healthcare providers and the Indian Revised National TB Control Programme will need to consider implementing infection control interventions in hospitals and health care centers in order to reduce nosocomial transmission and protect health care workers. With the WHO TBIC policy guidelines now available,[4] the emphasis should be on improving the safety of health care workers in India. Indeed, the Indian RNTCP has recently published guidance on airborne infection control in healthcare settings, but implementation of this guideline has been weak. [23] Our data suggests that the RNTCP guidelines must be urgently implemented, especially among young nursing and healthcare trainees because of their higher risk of TB infection and disease.

A recent modeling study from India examined the likely benefits of IPT as an intervention to reduce TB rates in Indian HCWs.[24] This analysis showed that implementation of IPT after serial tuberculin skin testing, along with other general TBIC measures, can have a large impact, especially in young HCWs and trainees. In this subgroup of young HCWs, the benefits outweighed the potential risks and adverse effects of IPT.

While testing all HCWs in India is daunting, we think a strong case can be made for at least doing annual TSTs on young HCWs and trainees – especially medical and nursing students, interns, allied health sciences students who are at risk of TB exposure, and postgraduates during their residency training.[25] In these groups, TST can be an integral component of pre-training/employment screening at the start of training, and repeated every year to identify those who are newly infected. Such convertors must then be screening to rule out active TB disease, before initiation of preventive therapy.

The rate-limiting step for Indian hospitals and administrators, we suspect, is not lack of resources. After all, TST screening and isoniazid therapy are inexpensive, and most large hospitals already have the required expertise in hospital infection control committees. The real problem may be apathy, unwillingness to act on available evidence, and a fatalistic acceptance that TB risk is part and parcel of being a healthcare professional in India [25].

Acknowledgments

We are grateful to all the student nurses at the Christian Medical College, Vellore, for their participation in our study. We also appreciate the support of College of Nursing, CMC, Vellore.

Author Contributions

Conceived and designed the experiments: DJC PD MP. Performed the experiments: DJC PD LA PJ BTJI BT BP. Analyzed the data: AZ MP. Contributed reagents/materials/analysis tools: DJC. Wrote the paper: DJC AZ MP. Provided funding: MP.

References

  1. 1. WHO (2010) WHO Global Tuberculosis Control: WHO Report 2010. Geneva: World Health Organization. WHO2010WHO Global Tuberculosis Control: WHO Report 2010.GenevaWorld Health Organization
  2. 2. Joshi R, Reingold AL, Menzies D, Pai M (2006) Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med 3: e494.R. JoshiAL ReingoldD. MenziesM. Pai2006Tuberculosis among health-care workers in low- and middle-income countries: a systematic review.PLoS Med3e494
  3. 3. Menzies D, Joshi R, Pai M (2007) Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 11: 593–605.D. MenziesR. JoshiM. Pai2007Risk of tuberculosis infection and disease associated with work in health care settings.Int J Tuberc Lung Dis11593605
  4. 4. Organization WH (2009) WHO Policy on TB infection control in health-care facilities, congregate settings and households. Geneva, Switzerland: Stop TB Department, World Health Organization. pp. 1–144.Organization WH2009WHO Policy on TB infection control in health-care facilities, congregate settings and households.Geneva, SwitzerlandStop TB Department, World Health Organization1144
  5. 5. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri SP, et al. (2005) Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood, interferon-g assay with tuberculin skin testing. JAMA 293: 2746–2755.M. PaiK. GokhaleR. JoshiS. DograSP Kalantri2005Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood, interferon-g assay with tuberculin skin testing.JAMA29327462755
  6. 6. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, et al. (2006) Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 174: 349–355.M. PaiR. JoshiS. DograDK MendirattaP. Narang2006Serial testing of health care workers for tuberculosis using interferon-gamma assay.Am J Respir Crit Care Med174349355
  7. 7. Menzies D (1999) Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159: 15–21.D. Menzies1999Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.Am J Respir Crit Care Med1591521
  8. 8. Dheda K, van Zyl Smit R, Badri M, Pai M (2009) T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 15: 188–200.K. DhedaR. van Zyl SmitM. BadriM. Pai2009T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings.Curr Opin Pulm Med15188200
  9. 9. Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761–776.M. PaiLW RileyJM Colford Jr2004Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.Lancet Infect Dis4761776
  10. 10. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, et al. (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54: 49–55.GH MazurekJ. JerebP. LobueMF IademarcoB. Metchock2005Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.MMWR Recomm Rep544955
  11. 11. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177–184.M. PaiA. ZwerlingD. Menzies2008Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.Ann Intern Med149177184
  12. 12. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, et al. (2011) Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax. A. ZwerlingS. van den HofJ. ScholtenF. CobelensD. Menzies2011Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review.Thorax
  13. 13. Swindells JE, Aliyu SH, Enoch DA, Abubakar I (2009) Role of interferon-gamma release assays in healthcare workers. J Hosp Infect 73: 101–108.JE SwindellsSH AliyuDA EnochI. Abubakar2009Role of interferon-gamma release assays in healthcare workers.J Hosp Infect73101108
  14. 14. Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, et al. (2011) Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. MX RangakaKA WilkinsonJR GlynnD. LingD. Menzies2011Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis.Lancet Infect Dis
  15. 15. Christopher DJ, Daley P, Armstrong L, James P, Gupta R, et al. (2010) Tuberculosis infection among young nursing trainees in South India. PLoS ONE 5: e10408.DJ ChristopherP. DaleyL. ArmstrongP. JamesR. Gupta2010Tuberculosis infection among young nursing trainees in South India.PLoS ONE5e10408
  16. 16. CTDTI (2009) RNTCP Status Report. New Delhi, India. pp. 1–72.CTDTI2009RNTCP Status Report.New Delhi, India172
  17. 17. Gopinath KG, Siddique S, Kirubakaran H, Shanmugam A, Mathai E, et al. (2004) Tuberculosis among healthcare workers in a tertiary-care hospital in South India. J Hosp Infect 57: 339–342.KG GopinathS. SiddiqueH. KirubakaranA. ShanmugamE. Mathai2004Tuberculosis among healthcare workers in a tertiary-care hospital in South India.J Hosp Infect57339342
  18. 18. ATS (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 161: S221–247.ATS2000Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.Am J Respir Crit Care Med161S221247
  19. 19. ATS (2000) Diagnostic Standards and Classification of Tuberculosis in Adults and Children . This Official Statement of the American Thoracic Society and the Centers for Disease Control and Prevention was Adopted by the ATS Board of Directors, July 1999. This Statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 161: 1376–1395.ATS2000Diagnostic Standards and Classification of Tuberculosis in Adults and Children . This Official Statement of the American Thoracic Society and the Centers for Disease Control and Prevention was Adopted by the ATS Board of Directors, July 1999. This Statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.Am J Respir Crit Care Med16113761395
  20. 20. Veening GJ (1968) Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults. Bull Int Union Tuberc 41: 169–171.GJ Veening1968Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults.Bull Int Union Tuberc41169171
  21. 21. Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, et al. (2011) The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med 8: e1001012.A. ZwerlingMA BehrA. VermaTF BrewerD. Menzies2011The BCG World Atlas: a database of global BCG vaccination policies and practices.PLoS Med8e1001012
  22. 22. Farhat M, Greenaway C, Pai M, Menzies D (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10: 1192–1204.M. FarhatC. GreenawayM. PaiD. Menzies2006False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?Int J Tuberc Lung Dis1011921204
  23. 23. RNTCP I (2010) Guidelines on Airborne Infection Control in Healthcare and Other Settings. New Delhi: Indian RNTCP. I. RNTCP2010Guidelines on Airborne Infection Control in Healthcare and Other Settings.New DelhiIndian RNTCP
  24. 24. Raj R, Prasad H, Arya BK, Bhattacharya SD (2011) Translating evidence into policy: The case for isoniazid preventive therapy programmes for healthcare workers in India. The National Medical Journal of India 24: 4.R. RajH. PrasadBK AryaSD Bhattacharya2011Translating evidence into policy: The case for isoniazid preventive therapy programmes for healthcare workers in India.The National Medical Journal of India244
  25. 25. Pai M, Christopher DJ (2011) Protecting young healthcare trainees from tuberculosis: Can we overcome apathy? The National Medical Journal of India 24: 198–200.M. PaiDJ Christopher2011Protecting young healthcare trainees from tuberculosis: Can we overcome apathy?The National Medical Journal of India24198200